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Transcription factors and chromatin modifiers are known to contribute to cell specification. However,
whether and how they jointly act is poorly understood. In this issue of Cell Stem Cell, Ninkovic et al. show
that Pax6 and Brg1 cooperate to modulate gene expression in order to direct neurogenic fate in the olfactory
bulb.Since the discovery of adult neurogenesis
by Joseph Altman over 50 years ago, it
has been clear that the postnatal produc-
tion of neurons only occurs in very spe-
cific contexts. Stem cell proliferation and
differentiation are tightly controlled and
balanced by the combined contribu-
tions of microenvironment, intrinsic gene
expression (Ninkovic and Go¨tz, 2007),
and epigenetic mechanisms (Ma et al.,
2010). Given that both neurons and glia
are generated from the adult stem cell
niche, considerable efforts have gone
into determining genetic factors that act
in the specification of cell fate. Three of
the best studied are Pax6, Olig2, and
Dlx2. Pax6 has been previously shown
to be sufficient to direct adult olfactory
bulb (OB) neurogenesis and even repro-
gram glia into neurons (Hack et al.,
2005; Heins et al., 2002). However, the
downstream molecular mechanisms uti-
lized by Pax6 and other transcription
factors are poorly elucidated. Epige-
netic control of neuronal precursor fate,
through chromatin remodeling, consti-
tutes another regulatory modality (Lim
et al., 2009; Seo et al., 2005). Mechanisti-
cally, the BAF complex allows the histone
octamere to slide along the DNA, which
exerts a tight control on gene loci acces-
sibility and expression. However, epige-
netic functionality has to date not been
well reconciled with transcriptional regu-
lation. In this issue of Cell Stem Cell, Nin-
kovic et al. (2013) report an intriguing
cooperation between the master regula-
tory gene Pax6 and the BAF complex
member Brg1. This functional interaction
promotes neuronal fate through theestablishment of a small network of core-
gulated genes.
Ninkovic et al. (2013) investigated the
role of Brg1 in OB neurogenesis. This
work stemmed from their realization that
a physical interaction between Brg1 and
Pax6 exists within Dcx+ neuroblasts.
Moreover, they observed that the pheno-
type resulting from GlastCreER removal
of Brg1 is characterized by a dramatic
reduction in neuronal fates. First, to
examine these fate decisions, they under-
took a heroic experiment where they used
single-cell videomicroscopy to follow
the fate of individual neuroblasts over a
week. Second, they used retroviral vec-
tors to locally induce Cre-mediated Brg1
removal in rapidly proliferating transient
amplifying cells and neuroblasts. These
experiments allowed the authors to
convincingly ascertain that a delayed
gliogenic fate switch occurs in potential
neuroblasts within the subependymal
zone (SEZ) and rostral migratory stream
(RMS) of Brg1 conditional knockout
(cKO) mice. Interestingly, thesemanipula-
tions reproduced the result observed
upon Pax6 removal in this same context
(Hack et al., 2005). Altogether, these
results suggest that Pax6 operates in
conjunction with Brg1 to coregulate
gene expression during SEZ neurogene-
sis. Further strengthening this conclusion,
the authors report that 90% of the genes
whose expression is downregulated in
Brg1 cKO SEZ also carry putative Pax6
binding sites.
To demonstrate causality in this
context, they elegantly demonstrated
that Pax6 gain of function in the Brg1 KOCell Stem Cell 1background was unable to rescue the
phenotype. Only the re-expression of
exogenous Brg1 with an intact ATPase
catalytic domain was able to efficiently
complement the defective neurogenesis
and potentiate Pax6-mediated neuro-
genesis. Although details of these inter-
actions remain to be elucidated, the
authors provide a clear indication of the
gene cascade this complex regulates.
By examining the transcription factors
bearing putative Pax6 binding sites that
are expressed in the SEZ/RMS niche
and downregulated in both Brg1 and
Pax6 loss of-function, Ninkovic et al.
(2013) identified Pou3f4, Sox11, and Nfib
as candidate downstream effectors.
Moreover, the authors provide a hint to
the subsequent regulatory interactions
between these genes by demonstrating
that Sox11 induces a dramatic fold in-
crease in the net expression of this gene
group and further showed their ability to
enhance neurogenesis downstream of
Brg1 function. Moreover, a gain-of-func-
tion experiment even revealed their ability
to directly induce the neurogenic conver-
sion of postnatal glial cells into neurons
in vitro. With these experiments, Ninkovic
et al. (2013) reveal the existence of a small
group of proneural effector genes whose
expression is initially promoted by Brg1-
dependent Pax6 transcriptional activity
and whose expression is sustained
by their cross-regulatory and reciprocal
activities.
This work sheds light onto the require-
ment of interactions between transcrip-
tion factors with chromatin remodelers
in order to facilitate gene transcription.3, October 3, 2013 ª2013 Elsevier Inc. 373
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the gliogenic transcription factor Olig2
can also promote the recruitment of
Brg1 to enhancer elements already occu-
pied by Olig2 during oligodendrocyte dif-
ferentiation. In this particular context,
Brg1 activation coincides with and drives
oligodendrocyte differentiation and fate
specification. During adult OB neurogen-
esis, it seems likely that Pax6 recruits
Brg1, which, in turn, sculpts the chromatin
landscape, thus potentiating Pax6-medi-
ated transcription of a neurogenic pro-
gram. However unlike oligodendrocyte
lineages, Pax6 shows a highly dynamic
expression in this niche, while Brg1 is
ubiquitously expressed. This suggests
that Brg1 may be awaiting interaction
with Pax6 at the initiation of neurogenesis
or be recruited away from other DNA
binding sites upon its appearance.
Moreover, investigating the regulation
of the Brg1-Pax6 interaction should prove
interesting. It has yet to be determined
whether posttranscriptional or posttrans-
lational modifications promote interac-
tions between Brg1 and Pax6 or Brg1
and Olig2. Structural analyses should
help to examine these possibilities and
may also lead to the identification of addi-
tional proteins involved in BAF-complex
and transcription factor interactions,
which very likely differ on the basis of
circumstance. Specifically, the compo-
nents recruited almost certainly depend374 Cell Stem Cell 13, October 3, 2013 ª201on whether Brg1 is interacting with Pax6
or Olig2. Indeed, it seems likely that the
differential recruitment of the BAF com-
plex by distinct transcription factors dic-
tates the specific fate decision chosen
by a particular progenitor in a context-
dependent manner.
Although Ninkovic et al. (2013) provide
insight toward understanding neuronal
versus glial fate specification in the stem
cell niche, whether this complex is also
involved in the subsequent selection of a
specific neuronal cell type remains an
open question. Intriguingly, they observed
that neurons of the superficial granular
cell layer (GCL) are spared in Brg1 cKO,
whereas deep GCL and glomerular layer
(GL) neuronal populations are both
severely decreased. Given that specific
neuronal cell types populate these re-
gions, it implies a more nuanced role for
this complex in the selection of neuronal
subtype. Specifically, neuroblasts born
in the postnatal SEZ or along the RMS
terminally differentiate into GABAergic
and dopaminergic interneurons in the
GCL and GL, respectively (Batista-Brito
et al., 2008; Betarbet et al., 1996). Thus,
the different effects on the dGCL and GL
versus the sGCL neuronal subsets sug-
gest that Pax6 and Brg1 may also deter-
mine the specification of different OB
neuron sublineages. Hence, the elegant
genetic work of Ninkovic et al. (2013)
opens the door toward the possibility3 Elsevier Inc.that chromatin modifiers and transcrip-
tion factors could jointly instruct not
only cell type but also subtype fate
specification.REFERENCES
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